Dr. M Tikly share #rheum challenges & solutions in South Africa: 👉⬆️training to gen. practitioners & nurses, 👉estab outreach clinics 👉lobby local government/political groups 👉use of off-label drugs 👉engage pharma: free meds/clinical trials #ACR22 #GlobalHealth @rheumnow https://t.co/BX2qXk1usN

Dr. Tikly discusses the solutions to drug access challenges in South Africa in both state and private sectors 👇 🔸Off label use, buyouts, price⬇️, advocacy... Highly relatable because these are similar challenges we face in the PH @rheumarhyme @doktora_ging #ACR22 @rheumnow https://t.co/ajshylgtIE

Finally we're starting to get therapies for polymyalgia rheumatica! The best of PMR therapeutics coming up at #ACR22 (and catch it all @RheumNow): https://t.co/lUPICA3Mim

#ACR22 Presents New Data on JIA Clinical Remission with Combo DMARDSs New research being presented at #ACR22, demonstrated that polyarticular juvenile idiopathic arthritis patients were more likely to achieve clinical remission with combo DMARDSs. https://t.co/qmfnEvDedA https://t.co/VhkYlZJG3s

Update: axSpA Recommendations https://t.co/KaBb11WLQD https://t.co/8kIaa0WuvM

Study of 78 824 adults shows Prevalence of Cannabis use was significantly higher during the pandemic vs before the pandemic in states where it is legalized (but not increase in nonlegal states) esp in adults 18 to 29 and 30 to 54 years https://t.co/ZZzCl7dstj https://t.co/qbQLPhI6I8

Dr. Yuz Yusof will be covering #ACR22 as a RheumNow reporter again. He'll be sharing real-time coverage on SLE, auto-inflammatory and COVID. Follow @Yuz6Yusof! https://t.co/3rYlIrM54m

Chronic Pain increased from 2010-2919. A cross-sectional study of 46 420 respondents, shows nonpharmacologic Rx increased [aOR 2.72] & was greater than opioids for chronic, but not surgical pain. Govt policy & practice guidelines have helped. https://t.co/31oS0xWRMW https://t.co/IvkDRJQvT8

Sleep Habits study from NHANES - 9004 adults >20 yrs (2017-2020) finds mean sleep duration 7.6 hrs on workdays & 8.2 hrs on free days; 23% slept <7 hrs & 25% went to bed > midnight. Nearly 30% had trouble sleeping (daytime sleepiness 27%) https://t.co/Uc7nL4q3fm https://t.co/qvCwqbsez1

Follow RheumNow reporter, Dr. Eric Dein, for real-time #ACR22 coverage! https://t.co/NZkVd2A989

Our newest RheumNow reporter, Dr. Michael Putman , will be covering SLE and Vasculitis at #ACR22 this year. “Looking forward to seeing all my friends and colleagues in person!”-Dr. Putnam Follow him @EBRheum for real-time coverage! https://t.co/DpFa0zwzPX